Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
The global insulin pens market size was valued at USD 7.46 billion in 2024 and is projected to reach from USD 8.05 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback